Clinical Trials Directory

Trials / Sponsors / Cardiff Oncology

Cardiff Oncology

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and
Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation
Phase 22024-02-27
CompletedStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Lin
Colorectal Cancer, Metastatic Colorectal Cancer
Phase 22023-03-17
CompletedOnvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatme
Pancreatic Ductal Adenocarcinoma
Phase 22021-05-25
CompletedOnvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Can
Metastatic Colorectal Cancer, KRAS Gene Mutation
Phase 1 / Phase 22019-06-24
CompletedOnvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resist
Metastatic Castration-Resistant Prostate Cancer
Phase 22018-08-14
CompletedOnvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid
Acute Myeloid Leukemia
Phase 1 / Phase 22017-11-17
No Longer AvailableExpanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With
Metastatic Colorectal Cancer, KRAS Gene Mutation
——